160 related articles for article (PubMed ID: 26170622)
1. Dose-dependent effects of atorvastatin on myocardial infarction.
Barbarash O; Gruzdeva O; Uchasova E; Belik E; Dyleva Y; Karetnikova V
Drug Des Devel Ther; 2015; 9():3361-8. PubMed ID: 26170622
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction.
Aydin MU; Aygul N; Altunkeser BB; Unlu A; Taner A
Atherosclerosis; 2015 Apr; 239(2):439-43. PubMed ID: 25697576
[TBL] [Abstract][Full Text] [Related]
3. Impact of the statin escape phenomenon on long-term clinical outcomes in patients with acute myocardial infarction: Subgroup analysis of the Nagoya Acute Myocardial Infarction Study (NAMIS).
Ota T; Ishii H; Suzuki S; Shibata Y; Tatami Y; Harata S; Shimbo Y; Takayama Y; Tanaka A; Kawamura Y; Osugi N; Maeda K; Kondo T; Murohara T
Atherosclerosis; 2015 Sep; 242(1):155-60. PubMed ID: 26188539
[TBL] [Abstract][Full Text] [Related]
4. Lipid, adipokine and ghrelin levels in myocardial infarction patients with insulin resistance.
Gruzdeva O; Uchasova E; Belik E; Dyleva Y; Shurygina E; Barbarash O
BMC Cardiovasc Disord; 2014 Jan; 14():7. PubMed ID: 24433403
[TBL] [Abstract][Full Text] [Related]
5. [Lipid, adipokine and ghrelin concentrations in myocardial infarction patients with insulin resistance].
Gruzdeva OV; Karetnikova VN; Akbasheva OE; Fedorova TS; Belik EV; Palicheva EI; Uchasova EG; Dyleva IuA; Brazovskaia NG; Barbarash OL
Vestn Ross Akad Med Nauk; 2013; (7):13-9. PubMed ID: 24340956
[TBL] [Abstract][Full Text] [Related]
6. Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose.
Buldak L; Dulawa-Buldak A; Labuzek K; Okopien B
Int J Clin Pharmacol Ther; 2012 Nov; 50(11):805-13. PubMed ID: 22943927
[TBL] [Abstract][Full Text] [Related]
7. Titration to High-Intensity Statin Therapy Following Acute Myocardial Infarction in Patients With and Without Diabetes Mellitus.
Giustino G; Colantonio LD; Brown TM; Carson AP; Dai Y; Farkouh ME; Monda KL; Muntner P; Rosenson RS
Cardiovasc Drugs Ther; 2018 Oct; 32(5):453-461. PubMed ID: 30078077
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial.
Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y
JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994
[TBL] [Abstract][Full Text] [Related]
9. Lipid Testing and Statin Dosing After Acute Myocardial Infarction.
Wang WT; Hellkamp A; Doll JA; Thomas L; Navar AM; Fonarow GC; Julien HM; Peterson ED; Wang TY
J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29371200
[TBL] [Abstract][Full Text] [Related]
10. Statins Are Associated With Increased Insulin Resistance and Secretion.
Abbasi F; Lamendola C; Harris CS; Harris V; Tsai MS; Tripathi P; Abbas F; Reaven GM; Reaven PD; Snyder MP; Kim SH; Knowles JW
Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):2786-2797. PubMed ID: 34433298
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study.
Anagnostis P; Selalmatzidou D; Polyzos SA; Panagiotou A; Slavakis A; Panagiotidou A; Athyros VG; Karagiannis A; Mikhailidis DP; Kita M
Int J Clin Pract; 2011 Jun; 65(6):679-83. PubMed ID: 21564441
[TBL] [Abstract][Full Text] [Related]
12. Effect of low doses of atorvastatin on adiponectin, glucose homeostasis, and clinical inflammatory markers in kidney transplant recipients.
Bayés B; Granada ML; Lauzurica R; Pastor MC; Navarro M; Bonet J; Llopis MA; Romero R
Transplant Proc; 2005 Nov; 37(9):3808-12. PubMed ID: 16386546
[TBL] [Abstract][Full Text] [Related]
13. Differential Effects of Atorvastatin and Pitavastatin on Inflammation, Insulin Resistance, and the Carotid Intima-Media Thickness in Patients with Dyslipidemia.
Nakagomi A; Shibui T; Kohashi K; Kosugi M; Kusama Y; Atarashi H; Shimizu W
J Atheroscler Thromb; 2015; 22(11):1158-71. PubMed ID: 26084792
[TBL] [Abstract][Full Text] [Related]
14. A Multi-Center, Open-Label, Two-Arm Parallel Group Non-inferiority Randomized Controlled Trial Evaluating the Effect of Pitavastatin, Compared to Atorvastatin, on Glucose Metabolism in Prediabetics with Hypertension and Dyslipidemia: Rationale and Design for the China Hemoglobin A1c Metabolism Protection Union Study (CAMPUS).
Zhang J; Shao Y; Liu Y; Tao J
Cardiovasc Drugs Ther; 2018 Dec; 32(6):581-589. PubMed ID: 30187345
[TBL] [Abstract][Full Text] [Related]
15. Effect of a hydrophilic and a hydrophobic statin on cardiac salvage after ST-elevated acute myocardial infarction - a pilot study.
Chitose T; Sugiyama S; Sakamoto K; Shimomura H; Yamashita T; Hokamaki J; Tsunoda R; Shiraishi S; Yamashita Y; Ogawa H
Atherosclerosis; 2014 Nov; 237(1):251-8. PubMed ID: 25262434
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of statin on reduction of angiopoietin-like 2 and glyceraldehyde-derived advanced glycation end-products levels in patients with acute myocardial infarction: a message from SAMIT (Statin for Acute Myocardial Infarction Trial).
Shimomura M; Oyama J; Takeuchi M; Shibata Y; Yamamoto Y; Kawasaki T; Komoda H; Kodama K; Sakuma M; Toyoda S; Inoue Y; Mine D; Natsuaki M; Komatsu A; Hikichi Y; Yamagishi S; Inoue T; Node K
Heart Vessels; 2016 Oct; 31(10):1583-9. PubMed ID: 26699899
[TBL] [Abstract][Full Text] [Related]
17. Effect of atorvastatin (10 mg/day) on glucose metabolism in patients with the metabolic syndrome.
Huptas S; Geiss HC; Otto C; Parhofer KG
Am J Cardiol; 2006 Jul; 98(1):66-9. PubMed ID: 16784923
[TBL] [Abstract][Full Text] [Related]
18. Effect of different doses of statins on the development of type 2 diabetes mellitus in patients with myocardial infarction.
Gruzdeva O; Uchasova E; Dyleva Y; Akbasheva O; Karetnikova V; Shilov A; Barbarash O
Diabetes Metab Syndr Obes; 2017; 10():481-489. PubMed ID: 29255368
[TBL] [Abstract][Full Text] [Related]
19. [The impact of different doses of atorvastatin on plasma endothelin and platelet function in acute ST-segment elevation myocardial infarction after emergency percutaneous coronary intervention].
Xu XR; Li KB; Wang P; Xu L; Liu Y; Yang ZS; Yang XC
Zhonghua Nei Ke Za Zhi; 2016 Dec; 55(12):932-936. PubMed ID: 27916047
[No Abstract] [Full Text] [Related]
20. [Atorvastatin in the treatment of high risk patients with ischemic heart disease and dyslipidemia. Safety assessment in the Russian Multicenter Study ATLANTIKA].
Mareev VIu
Kardiologiia; 2010; 50(9):4-14. PubMed ID: 21118160
[No Abstract] [Full Text] [Related]
[Next] [New Search]
